Tetracycline and erythromycin resistance among clinical isolates of Branhamella catarrhalis.
AUTOR(ES)
Brown, B A
RESUMO
We reviewed tetracycline and erythromycin disk diffusion susceptibility of 457 isolates of Branhamella catarrhalis. Four isolates were resistant to tetracycline, with MICs for two available isolates of 16 micrograms/ml. Sixteen isolates were in the moderately susceptible range for erythromycin, with an MIC for one available isolate being greater than 8 micrograms/ml. These are the first tetracycline- and (by MIC) erythromycin-resistant B. catarrhalis isolates reported from the United States.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=172719Documentos Relacionados
- Genetic basis of tetracycline resistance in Moraxella (Branhamella) catarrhalis.
- In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis.
- Pneumonia due to Branhamella catarrhalis.
- In vitro activity of cefpodoxime proxetil (U-76,252; CS-807) against clinical isolates of Branhamella catarrhalis.
- Defined medium for Moraxella (Branhamella) catarrhalis.